Go Pro
→ Porter flew 3,300 miles to investigate this system (From Porter & Company) (Ad)tc pixel Free PRQR Stock Alerts

ProQR Therapeutics (PRQR) News Today

ProQR Therapeutics logo
$2.34 +0.07 (+3.08%)
As of 08/21/2026 04:00 PM Eastern
Compare

ProQR Therapeutics Latest News

Bank of America Initiates Coverage on ProQR Therapeutics (NASDAQ:PRQR)
August 22 at 1:54 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30975424
ProQR Therapeutics: Buy For Axiomer RNA Tech Validation And Other Catalysts
August 21 at 5:00 PM  |  seekingalpha.comhttps://seekingalpha.com/article/4939234-proqr-therapeutics-buy-for-axiomer-rna-tech-validation-and-other-catalysts
HC Wainwright Issues Pessimistic Estimate for PRQR Earnings
August 21 at 2:03 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30973398
ProQR Therapeutics (NASDAQ:PRQR) Earns Buy Rating from Analysts at Bank of America
August 20 at 8:05 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/proqr-therapeutics-nasdaqprqr-earns-buy-rating-from-analysts-at-bank-of-america-2026-08-20/
HC Wainwright Has Optimistic Outlook of PRQR FY2030 Earnings
August 20 at 2:12 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30971455
HC Wainwright Expects Lower Earnings for ProQR Therapeutics
August 19, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/hc-wainwright-expects-lower-earnings-for-proqr-therapeutics-2026-08-19/
Equities Analysts Set Expectations for PRQR FY2030 Earnings
August 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/equities-analysts-set-expectations-for-prqr-fy2030-earnings-2026-08-18/
ProQR Reports Higher Revenue but Ongoing Losses in Second Quarter 2026 Results
August 15, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/PRQR/pressreleases/3849242/proqr-reports-higher-revenue-but-ongoing-losses-in-second-quarter-2026-results/
ProQR posts Q2 2026 results as Axiomer RNA editing gains first clinical validation
August 15, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/PRQR/pressreleases/3849238/proqr-posts-q2-2026-results-as-axiomer-rna-editing-gains-first-clinical-validation/
ProQR Therapeutics (NASDAQ:PRQR) Rating Increased to Hold at Wall Street Zen
August 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/proqr-therapeutics-nasdaqprqr-rating-increased-to-hold-at-wall-street-zen-2026-08-15/
ProQR Therapeutics (NASDAQ:PRQR) Announces Earnings Results
August 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/proqr-therapeutics-nasdaqprqr-announces-earnings-results-2026-08-14/
ProQR Therapeutics Reports First Clinical Validation of Axiomer RNA Editing Platform, Positive AX-0810 Data and Upcoming Pipeline Milestones
August 13, 2026  |  quiverquant.comQ
ProQR Announces Second Quarter 2026 Operating and Financial Results
August 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/13/3344335/33039/en/proqr-announces-second-quarter-2026-operating-and-financial-results.html
ProQR Therapeutics N.V. (NASDAQ:PRQR) Receives Average Rating of "Moderate Buy" from Analysts
August 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/proqr-therapeutics-nv-nasdaqprqr-receives-average-rating-of-moderate-buy-from-analysts-2026-08-04/
ProQR Therapeutics (PRQR) to Announce Earnings on Thursday
July 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/proqr-therapeutics-prqr-to-announce-earnings-on-thursday-2026-07-30/
ProQR Therapeutics N.V. (NASDAQ:PRQR) Short Interest Up 92.5% in July
July 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/proqr-therapeutics-nv-nasdaqprqr-short-interest-up-925-in-july-2026-07-30/
Bart Filius Purchases 150,000 Shares of ProQR Therapeutics (NASDAQ:PRQR) Stock
July 29, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-prqr-insider-buying-and-selling-2026-07-29/
ProQR Therapeutics (NASDAQ:PRQR) Director Bart Filius Buys 150,000 Shares
July 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/proqr-therapeutics-nasdaqprqr-director-bart-filius-buys-150000-shares-2026-07-28/
Oppenheimer Reaffirms Their Buy Rating on ProQR (PRQR)
July 11, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/PRQR/pressreleases/3161283/oppenheimer-reaffirms-their-buy-rating-on-proqr-prqr/
ProQR Therapeutics: Human NTCP Data Strengthens The Axiomer Thesis
July 4, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4919843-proqr-therapeutics-human-ntcp-data-strengthens-the-axiomer-thesis
ProQR Therapeutics (NASDAQ:PRQR) Director Purchases 150,000 Shares of Stock
July 1, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-prqr-insider-buying-and-selling-2026-07-01/
ProQR prices $50M stock offering; secures $9.2M investment from Eli Lilly
June 25, 2026  |  msn.comhttps://www.msn.com/en-us/money/other/proqr-prices-50m-stock-offering-secures-9-2m-investment-from-eli-lilly/ar-AA26wgdi
ProQR posts early-stage trial data for liver disease candidate
June 25, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/proqr-posts-early-stage-trial-data-for-liver-disease-candidate/ar-AA26wsK9
ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement
June 25, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/25/3317380/33039/en/proqr-prices-50-0-million-underwritten-registered-direct-offering-and-concurrent-private-placement.html
ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform
June 25, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/25/3317367/33039/en/proqr-announces-positive-phase-1-target-engagement-data-for-ax-0810-establishing-first-clinical-validation-of-the-axiomer-rna-editing-platform.html
PRQR Share News Today
June 11, 2026  |  uk.investing.comhttps://uk.investing.com/equities/proqr-thera-news/13
ProQR Shareholders Approve Capital Increase, Board Changes at 2026 AGM
June 2, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/proqr-shareholders-approve-capital-increase-board-changes-at-2026-agm?utm_source=marketbeat.com&utm_medium=referral
ProQR Posts Wider Q1 2026 Loss but Maintains Strong Cash Position
May 17, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/PRQR/pressreleases/1902061/proqr-posts-wider-q1-2026-loss-but-maintains-strong-cash-position/
ProQR Therapeutics N.V. (NASDAQ:PRQR) Analysts Just Slashed This Year's Revenue Estimates By 22%
May 14, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/proqr-therapeutics-n-v-nasdaq-122553707.html
ProQR Announces First Quarter 2026 Operating and Financial Results
May 12, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/12/3292670/33039/en/proqr-announces-first-quarter-2026-operating-and-financial-results.html
ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform
May 11, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/11/3291841/33039/en/proqr-announces-multiple-upcoming-scientific-conference-presentations-highlighting-the-breadth-of-its-axiomer-rna-editing-platform.html
ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026
May 4, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/04/3286664/33039/en/proqr-announces-annual-general-meeting-of-shareholders-to-be-held-june-2-2026.html
ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors
April 30, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/30/3284762/33039/en/proqr-announces-nomination-of-dr-lykke-hinsch-gylvin-to-its-board-of-directors.html
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alkermes (ALKS), ProQR (PRQR) and Simulations Plus (SLP)
April 10, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/1242350/analysts-opinions-are-mixed-on-these-healthcare-stocks-alkermes-alks-proqr-prqr-and-simulations-plus-slp/
ProQR Therapeutics: Waiting On Proof As AX-0810 Data Approaches
April 10, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4889819-proqr-therapeutics-waiting-on-proof-as-ax-0810-data-approaches
ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event
April 8, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/08/3270485/33039/en/proqr-highlights-pipeline-expansion-and-multiple-upcoming-clinical-catalysts-at-investor-and-analyst-event.html
ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board
April 8, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/08/3270057/33039/en/proqr-announces-partnership-with-ginkgo-bioworks-and-formation-of-ai-advisory-board.html
Growing optimism about ProQR Therapeutics (PRQR)’s RNA editing platform and future clinical catalysts
March 26, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/growing-optimism-about-proqr-therapeutics-prqr-s-rna-editing-platform-and-future-clinical-catalysts/ar-AA1Zplum
ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026
March 25, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/25/3262136/33039/en/proqr-to-host-virtual-investor-and-analyst-event-highlighting-pipeline-on-april-8-2026.html
ProQR Therapeutics N.V. (PRQR) Presents at The Citizens Life Sciences Conference 2026 Transcript
March 18, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4883792-proqr-therapeutics-n-v-prqr-presents-at-the-citizens-life-sciences-conference-2026-transcript
ProQR Therapeutics N.V.: ProQR Announces Year End 2025 Operating and Financial Results
March 12, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-03/67926987-proqr-therapeutics-n-v-proqr-announces-year-end-2025-operating-and-financial-results-399.htm
ProQR Announces Year End 2025 Operating and Financial Results
March 12, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/12/3254449/33039/en/proqr-announces-year-end-2025-operating-and-financial-results.html
ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference
March 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/03/3248959/33039/en/proqr-announces-webcast-of-presentation-at-the-2026-citizens-life-sciences-conference.html
ProQR Announces Planned Changes to Board Composition
February 9, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/02/09/3234489/33039/en/proqr-announces-planned-changes-to-board-composition.html
ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook
January 8, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/01/08/3215343/33039/en/proqr-announces-encouraging-ax-0810-phase-1-safety-and-pk-data-development-candidate-selections-and-2026-outlook.html
ProQR Therapeutics N.V.'s (NASDAQ:PRQR) top owners are individual investors with 34% stake, while 29% is held by institutions
December 28, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/proqr-therapeutics-n-v-nasdaq-134118585.html
ProQR Therapeutics N.V. to Participate in 8th Annual Evercore Healthcare Conference on December 4, 2025
December 1, 2025  |  quiverquant.comQ
ProQR to Participate in 8th Annual Evercore Healthcare Conference
December 1, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/12/01/3196934/33039/en/proqr-to-participate-in-8th-annual-evercore-healthcare-conference.html
ProQR Therapeutics reports Q3 (EUR 0.10) vs (EUR 0.10) last year
November 7, 2025  |  msn.comhttps://www.msn.com/en-us/money/markets/proqr-therapeutics-reports-q3-eur-010-vs-eur-010-last-year/ar-AA1PWe6M
ProQR Reports Q3 2025 Financial Results Amid Revenue Decline
November 6, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/proqr-reports-q3-2025-financial-results-amid-revenue-decline?utm_source=marketbeat.com&utm_medium=referral

ProQR Therapeutics Media Mentions By Week

ProQR Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PRQR
News Sentiment
▼
0.32

0.65
▲
Average
Healthcare
News Sentiment

ProQR Therapeutics News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PRQR Articles
This Week
▼
13

2
▲
PRQR Articles
Average Week

ProQR Therapeutics Trends on MarketBeat

This week vs. last week
New Followers
1
-50%
Searches
2
-33%
Page Views
2,790
+34%
Get ProQR Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRQR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools

Related Companies
News and Trends Tools

This page (NASDAQ:PRQR) was last updated on 8/23/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel